Drug Profile
Estradiol transdermal - Rottapharm
Alternative Names: Armonil; Demestril; Dermestril; Dermestril Septem; Epiestrol; TradeilaLatest Information Update: 19 Dec 2021
Price :
$50
*
At a glance
- Originator Rottapharm
- Developer ESTEVE; Kyowa Kirin International; Pfizer; Recordati; Rottapharm Madaus; Sanofi
- Class Antineoplastics; Estradiol congeners; Estrenes; Hormonal replacements; Small molecules
- Mechanism of Action Estrogen receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Menopausal syndrome
Most Recent Events
- 18 Apr 2016 ProStrakan is now called Kyowa Kirin International
- 10 Oct 2014 Rottapharm Madaus has been acquired by Meda
- 21 Apr 2011 ProStrakan has been acquired by Kyowa Hakko Kirin